New screening study targets hidden diabetes and celiac disease in High-Risk communities
NCT ID NCT06908057
First seen Jun 25, 2026 · Last updated Aug 13, 2026 · Updated 3 times
Summary
This study is screening 115 underserved children and adults who are at risk for type 1 diabetes or celiac disease. Researchers will use blood tests to find early signs of these conditions, aiming to improve how we detect them. The goal is to catch these diseases sooner, especially in communities that often lack access to care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better, earlier screening for type 1 diabetes and celiac disease in underserved communities.
- What could go wrong
- This is an observational screening study, not a treatment trial. It may not directly improve health outcomes, and the screening methods tested may not prove more effective than current ones.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AdventHealth Translational Research Institute
Orlando, Florida, 32804, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an app and cash rewards tame type 1 diabetes in young adults?
- Smart insulin pump aims to end dangerous nighttime blood sugar swings
- Could diabetes be silently damaging your hearing?
- Could a lesson in Gluten-Free eating boost Kids' health?
- Wheat sensitivity linked to fatty liver? a new study investigates
- Hidden liver risk in type 1 diabetes: a new study investigates